Cardioprotective effect of ARB in old patients with hypertension and coronary artery disease - a multicenter trial.
Phase of Trial: Phase III
Latest Information Update: 22 Aug 2016
At a glance
- Drugs Irbesartan (Primary) ; Candesartan cilexetil; Valsartan
- Indications Coronary artery disease; Hypertension
- Focus Therapeutic Use
- 17 Aug 2016 Status changed from active, no longer recruiting to discontinued.
- 13 Aug 2013 Planned End Date changed from 30 Nov 2015 to 30 Nov 2016 as reported by University Hospital Medical Information Network - Japan.
- 13 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.